Jeffrey M. Gross is SVP & Research & Development at ANGIOTECH PHARMACEUTICALS INC (ANPI). They have made 5 open-market trades across 1 company since 2009, most recently 2011-05-12.
CIK 0001448731
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $85K since 2009, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ANPI | 36,000 | — |
Shares reported on the most recent Form 4, priced at the 2011-05-17 close. 1 holding could not be priced and is excluded from the total.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.